Issue 6, 2013
From the journal:

Food & Function

Microencapsulation of tannic acid for oral administration to inhibit carbohydrate digestion in the gastrointestinal tract

Wei Zhao,ab   Vidya Iyer,†c   Floirendo P. Flores,a   Erik Donhowea  and  Fanbin Kong*a  

* Corresponding authors

a Department of Food Science & Technology, University of Georgia, 100 Cedar Street, Athens, GA 30602-2610, USA
E-mail: fkong@uga.edu
Fax: +1-706-542-1050
Tel: +1-706-542-7773

b School of Food Science and Technology, Jiangnan University, No. 1800 Lihu Road, Wuxi 214122, China

c South Forsyth High School, 585 Peachtree Pkwy, Cumming, GA 30041, USA

Abstract

The prevalence of diabetes mellitus and obesity is rapidly rising worldwide. Recently, there is increasing evidence that phytochemicals such as polyphenols in our diet could directly inhibit the activities of key digestive enzymes, representing a novel method of controlling and preventing diabetes mellitus and obesity. More research is required to determine how to effectively utilize phytochemicals within the gastrointestinal (GI) tract to obtain maximum inhibition of digestive enzymes. This study investigated the inhibition effciency of tannic acid (TA) on α-amylase as compared with other potential inhibitors using an in vitro method. The inhibition mode and kinetics were studied. The results showed that tannic acid (TA) is more effective in inhibiting α-amylase than a commercial starch blocker (Phase 2 Starch Blocker), and some selected flavonoids and polyphenols including quercetin, rutin, and polyphenon from green tea. It is also found that inhibition of α-amylase by TA in the GI tract is difficult if administered orally due to the non-specific and reversible noncompetitive interaction between tannic acid and α-amylase or other proteins. Accordingly, a pH-sensitive delivery system using calcium-alginate microspheres encapsulating tannic acid was successfully developed for oral administration to inhibit carbohydrate digestion in the GI tract. The encapsulated TA in calcium-alginate microspheres could be protected from the proteins in the stomach, and sustain release and inhibit α-amylase activity in the small intestine.

Graphical abstract: Microencapsulation of tannic acid for oral administration to inhibit carbohydrate digestion in the gastrointestinal tract

About
Cited by
Related
Download options Please wait...

Article information

DOI
https://doi.org/10.1039/C3FO30374H
Article type
Paper
Submitted
12 Dec 2012
Accepted
05 Apr 2013
First published
08 Apr 2013

Food Funct., 2013,4, 899-905

Permissions

Request permissions

Microencapsulation of tannic acid for oral administration to inhibit carbohydrate digestion in the gastrointestinal tract

W. Zhao, V. Iyer, F. P. Flores, E. Donhowe and F. Kong, Food Funct., 2013, 4, 899 DOI: 10.1039/C3FO30374H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements